Inoviq Ltd Market Cap ($12.95 Million)
Market Cap & Net Worth: Inoviq Ltd (IIQ)
Inoviq Ltd market cap. Inoviq Ltd (AU:IIQ) has a market capitalization of $12.95 Million (AU$18.30 Million) as of November 12, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26256 globally and #1170 in its home market, demonstrating a -7.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inoviq Ltd's stock price AU$0.13 by its total outstanding shares 140775458 (140.78 Million). Also see IIQ cash generation efficiency for how efficiently the company converts equity into cash flow.
Inoviq Ltd Market Cap History (2016–2026)
Inoviq Ltd market cap history from 2016 to 2026. Data shows change from $98.57 Million to $12.95 Million (-14.93% CAGR). Check Inoviq Ltd stock price for real-time trading data and today's change.
Inoviq Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inoviq Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Inoviq Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
21.26x
Inoviq Ltd's market cap is 21.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $20.29 Million | $44.03K | -$2.60 Million | 460.84x | N/A |
| 2018 | $65.19 Million | $62.42K | -$1.82 Million | 1044.46x | N/A |
| 2019 | $101.60 Million | $8.73K | -$1.72 Million | 11638.00x | N/A |
| 2020 | $67.73 Million | $98.39K | -$3.25 Million | 688.42x | N/A |
| 2021 | $119.03 Million | $1.27 Million | -$11.15 Million | 93.65x | N/A |
| 2022 | $63.75 Million | $276.75K | -$18.20 Million | 230.35x | N/A |
| 2023 | $66.24 Million | $398.19K | -$8.97 Million | 166.35x | N/A |
| 2024 | $51.30 Million | $535.12K | -$6.55 Million | 95.86x | N/A |
| 2025 | $38.60 Million | $1.82 Million | -$6.93 Million | 21.26x | N/A |
Competitor Companies of IIQ by Market Capitalization
Companies near Inoviq Ltd in the global market cap rankings as of November 12, 2026. Also see IIQ asset base for a full breakdown of the balance sheet.
Key companies related to Inoviq Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #137 globally with a market cap of $166.21 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.82 Billion USD ( CN¥367.78 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $46.10 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $717.71 |
| #137 | Danaher Corporation | NYSE:DHR | $166.21 Billion | $235.31 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.82 Billion | CN¥148.70 |
| #578 | Natera Inc | NASDAQ:NTRA | $46.10 Billion | $319.82 |
Market Capitalization of Inoviq Ltd (2016–2026)
Market capitalization of Inoviq Ltd from 2016 to today. Between 2016 and today, Inoviq Ltd's market cap moved from $98.57 Million to $ 12.95 Million, with a yearly change of -14.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$12.95 Million | -66.45% |
| 2025 | AU$38.60 Million | -24.76% |
| 2024 | AU$51.30 Million | -22.56% |
| 2023 | AU$66.24 Million | +3.91% |
| 2022 | AU$63.75 Million | -46.44% |
| 2021 | AU$119.03 Million | +75.74% |
| 2020 | AU$67.73 Million | -33.33% |
| 2019 | AU$101.60 Million | +55.84% |
| 2018 | AU$65.19 Million | +221.31% |
| 2017 | AU$20.29 Million | -79.42% |
| 2016 | AU$98.57 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 12th, 2026 the market cap of Inoviq Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.95 Million USD |
| MoneyControl | $12.95 Million USD |
| MarketWatch | $12.95 Million USD |
| marketcap.company | $12.95 Million USD |
| Reuters | $12.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inoviq Ltd
INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non… Read more